PRESS-RELEASE ·Filed Apr 15, 2026
Press release: earnings
Actionable Insight • Neutral
Traders should monitor the upcoming May 6 earnings call for guidance on Q1 2026 and portfolio performance; absence of current quarter data limits immediate trading impact.
Final — all horizons settled through T+60d
RPRX ▲ +16.44% at T+60d
NEUTRAL call ✓ call won +16.44% · α vs SPY +9.39% · entry $48.48 → $56.45
T+1d
+3.14%
call +3.14% · α +1.92%
$50.00
settled 6mo ago
T+5d
+2.39%
call +2.39% · α +1.41%
$49.64
settled 5mo ago
T+20d
+9.84%
call +9.84% · α +4.02%
$53.25
settled 5mo ago
T+60d
+16.44%
call +16.44% · α +9.39%
$56.45
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Royalty Pharma announced it will report Q1 2026 financial results on May 6, 2026, with no financials released in this press release. The prior quarter (Q4 2025) reported EPS of $1.47, a 21.2% beat versus consensus of $1.21, though revenue was not disclosed here.
Key Financial Metrics
EPS
$1.47
est $1.21 · +21.5%
Rating
in line
Key Facts
- Company to report Q1 2026 results on May 6, 2026
- No financial data provided for Q1 2026 in this release
- Q4 2025 EPS was $1.47, beating $1.21 consensus by 21.2%
- Revenue for Q4 2025 was not disclosed in this document
- Recent insider selling: $1.6M over past 30 days
Financial Impact
Prior quarter EPS beat by 21.2%; no forward financials provided
eps
Risk Factors
- Lack of current financials reduces immediate analytical value
- Recent insider selling may signal caution despite prior beat
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3274898 |
18 reports for RPRX
100% Hit rate best @ T+60▲ +15.20%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 27d ago | Press Release | $60.59 $58.47 | ▲ +3.50% | ▲ +2.38% | $57.16 (+5.66%) |
Aug 19, 2026 6w ago | Insider Cluster | $61.73 $61.80 | ▲ +0.11% | ▲ +0.50% | $57.16 (−7.40%) |
Aug 12, 2026 7w ago | 144 | $58.56 $60.58 | ▲ +3.45% | ▲ +5.41% | $57.16 (−2.39%) |
Aug 5, 2026 8w ago | 8-K | $57.75 $59.22 | ▲ +2.55% | ▲ +2.19% | $57.16 (−1.02%) |
Jul 2, 2026 13w ago | Insider Cluster | $57.77 $57.96 | ▲ +0.33% | ▼ −0.60% | $57.16 (−1.06%) |
Jul 2, 2026 13w ago | Insider Cluster | $57.77 $57.96 | ▲ +0.33% | ▼ −0.60% | $57.16 (−1.06%) |
May 28, 2026 18w ago | Insider Cluster | $55.76 $55.87 | ▲ +0.20% | ▲ +2.72% | $57.16 (+2.51%) |
May 28, 2026 18w ago | 8-K | $55.76 $54.97 | ▼ −1.42% | ▼ −1.12% | $57.16 (+2.51%) |
May 22, 2026 19w ago | Insider Cluster | $54.50 $55.18 | ▲ +1.25% | ▼ −0.41% | $57.16 (+4.88%) |
May 15, 2026 19w ago | Insider Cluster | $52.07 $53.86 | ▲ +3.44% | ▲ +1.82% | $57.16 (+9.78%) |
Showing 10 of 18
US Market Status
Market Closed — Opens Mon (65h)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access